dr. siti aishah binti sulaiman

pensyarah universiti

institut perubatan molekul (umbi)

No. sambungan :  0391459070

No. rasmi:
UKM : 03 8921 5555



   Biografi :
  • Dr. Siti Aishah Sulaiman completed her Ph.D. in Medicine in 2015 with a thesis title of Early Life Determinants of β-Cell Function in The Sheep. In her Ph.D. project, she investigated the role of early life factor, the intrauterine growth restriction (IUGR) in the development of β-cells dysregulation and insulin resistance, in an animal model of IUGR. She also determined the window of an early life intervention for such progression, by a post-natal treatment of an anti-diabetic drug, Exendin-4. In 2016, she joined the UKM Medical Molecular Biology Institute (UMBI) as a postdoctoral research fellow. Here in UMBI, she performed the genome sequencing of colorectal and breast cancer patients, as well as be involved in the genome sequencing of hypercholesterolemia patients. At the same time, she also worked together with a psychiatrist to determine the expression profile of oxidative stress markers in Bipolar Disorder patients. Upon completed her postdoctoral fellowship, she was offered to be a research fellow in UMBI and is currently doing the research on non-coding RNA regulation of disease development, with a particular interest in the role of long non-coding RNAs (lncRNAs) in diabetes complications, such as Diabetic Nephropathy and Diabetic Cardiomyopathy as well as the Non-alcoholic Fatty Liver Disease. Since 2015 till now, she has published many articles, and have acquired RM 1,449,400 of research grants. Dr Siti Aishah has numerous experiences in designing and performing the molecular experiments and data analysis.

  • nurul syakima ab mutalib, tan shing cheng, siti aishah sulaiman, rahman jamal.  (2020).  adakah anda mewarisi gen untuk risiko serangan jantung?.  - 1. 

     

    siti aishah binti sulaiman;a. rahman bin a. jamal.  (2020).  functional role of mir-146b in fatty acids-induced hepatic metabolic syndrome in non-alcoholic fatty liver disease.  -

     

    tamil selvi loganathan, siti aishah sulaiman, nor azian abdul murad, shamsul azhar shah, abdul halim abdul gafor, rahman jamal, noraidatulakma abdullah.  (2020).  interactions among non-coding rnas in diabetic nephropathy.  - frontiers in pharmacology.  1-19. 

     

    noraidatulakma binti abdullah @ muda;a. rahman bin a. jamal;abdul halim bin abdul gafor;nor azian binti abdul murad;shamsul azhar bin shah;siti aishah binti sulaiman.  (2020).  urinary lncrnas in diabetic nephropathy patients as potential early biomarkers.  -

     

    siti a sulaiman, nadiah abu, nurul-syakima ab mutalib, teck yew low, rahman jamal.  (2019).  signatures of gene expression, dna methylation and micrornas of hepatocellular carcinoma with vascular invasion.  - future oncology.  2603-2617. 

     

    tamil selvi loganathan, siti aishah sulaiman, nor azian abdul murad, shamsul azhar shah, abdul halim abdul gafor, rahman jamal, noraidatulakma abdullah.  (2020).  interactions among non-coding rnas in diabetic nephropathy.  - frontiers in pharmacology.  1-19. 

     

    nadiah abu, hon kha wai, shivapriya jeyaraman, azyani yahaya, nik muhd aslan abdullah, muuatamarulain mustangin, siti aishah sulaiman, rahman jamal, nurul syakima ab mutalib.  (2019).  identification of differentially expressed circular rnas in chemoresistant colorectal cancer.  - epigenomics.  875-884. 

     

    siti aishah sulaiman, nur ilham ainaa muhsin, rahman jamal.  (2019).  regulatory non-coding rnas network in non-alcoholic fatty liver disease.  - frontiers in physiology. 

     

    siti a. sulaiman, miles j. de blasio, m. lyn harland, kathryn l. gatford, and julie a. owens.  (2017).  maternal methyl donor and cofactor supplementation in late pregnancy increases b-cell numbers at 16 days of life in growth-restricted twin lambs.  - american journal of physiology-endocrinology and metabolism. 

     

    ahmad r. arshad, siti a. sulaiman, amalia a. saperi , rahman jamal, norlinah mohamed ibrahim and nor azian abdul murad.  (2017).  micrornas and target genes as biomarkers for the diagnosis of early onset of parkinson disease.  - frontiers of molecular neuroscience.  1-20. 

     

    siti a sulaiman, nadiah abu, nurul-syakima ab mutalib, teck yew low, rahman jamal.  (2019).  signatures of gene expression, dna methylation and micrornas of hepatocellular carcinoma with vascular invasion.  - future oncology.  2603-2617. 

     
    Tiada Rekod
    Tiada Rekod
    Tiada Rekod

    nurul-syakima ab mutalib, siti aishah sulaiman and rahman jamal.  (2019).  computational epigenetics and diseases.  - 452. 

     

    siti aishah sulaiman, nor azian abdul murad, ezanee azlina mohamad hanif, nadiah abu, and rahman jamal.  (2018).  circular rna: biogenesis and function.  - 370. 

     

    noraidatulakma binti abdullah @ muda;a. rahman bin a. jamal;abdul halim bin abdul gafor;nor azian binti abdul murad;shamsul azhar bin shah;siti aishah binti sulaiman.  (2020).  urinary lncrnas in diabetic nephropathy patients as potential early biomarkers.  -

     

    siti aishah binti sulaiman;a. rahman bin a. jamal.  (2020).  functional role of mir-146b in fatty acids-induced hepatic metabolic syndrome in non-alcoholic fatty liver disease.  -

     

    nurul syakima ab mutalib, tan shing cheng, siti aishah sulaiman, rahman jamal.  (2020).  adakah anda mewarisi gen untuk risiko serangan jantung?.  - 1. 

     

    nor azian murad, siti aishah, mohd arman, muhidin ishak,.  (2019).  video perasmian sambutan hari dna umbi 2019.  - 1. 

     

    siti aishah sulaiman, nurruzanna ismail, tamil selvi loganathan, rahman jamal.  (2019).  silencing of mir-146b expression prevented insulin-resistance-induced by excessive fatty acids exposure in hepatocytes.  - diabetes asia conference 2019.  37.